Trump may be mystery patient in odd case of 79yo getting experimental obesity drug

Factual coreconfirmed by several independent voices

• White House spokesperson denied it was Trump only after story was published.

  reliability moderate2/2 sources

Reported detailssecondary facts, each attributed to its source

• When the 79-year-old patient requested “compassionate use” access to retatrutide in April, it was to treat refractory obesity with obstructive sleep apnea and pulmonary hypertension.

  according to The New Republic

• Asked whether Trump has obstructive sleep apnea and pulmonary hypertension, Desai originally told STAT a White House memo on Trump’s most recent medical evaluation “covers this.” It does not.

  according to The New Republic

• A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’

  according to The Independent

Disputedincompatible versions — to verify

No factual contradiction detected between sources.

Framing by sidesame fact, different words — loaded terms highlighted

No notable framing divergence.

Blind spotwhat one side keeps silent

• White House spokesperson denied it was Trump only after story was published.

  omitted byLeft sidecovered byLeft side

Sources4 sources cross-checked

Story timelinehow this story developed, day by day